Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Q2 2025/26 Earnings Presentation
4 slides from Coloplast A/s Class B's earnings presentation, 2026
Slide 1: Conference call 2025/26 - Making life easier
Conference call 2025/26 Making life easier Impact4: Setting the standard of care at scale Julia | User, Continence Care
Slide 2: Forward-looking statements
Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements
Slide 3: Q2 2025/26 financial result and revised guidance FY 2025/26
Q2 2025/26 financial result Revised guidance FY 2025/26 Organic EBIT growth* ROIC** Organic growth in constant currencies 5-6% revenue growth 6% 6% 15% * Reported revenue growth in DKK Around 3% EBIT growth* in Around 5% constant currencies Organic revenue growth by business area in Q2 8% 8% 8% ROIC
Slide 4: Making life easier for people with intimate healthcare needs
Mission Making life easier for people with intimate healthcare needs Values Closeness… to better understand Passion… to make a difference Respect and responsibility… to guide us Vision Setting the global standard for listening and responding